Kendra J. Grubb, MD

Surgical Director, Structural Heart and Valve Center
Emory University
Atlanta, Georgia, United States

Dr. Kendra J. Grubb, MD, MHA, FACC, is an adult cardiac surgeon in Atlanta, Georgia and since 2018 has served as the Surgical Director of the Structural Heart and Valve Center, Emory University. Dr. Grubb is dedicated to improving the lives of patients through innovation and building collaborative teams to promote patient-centered treatment of cardiovascular disease. Previously, she was Director of Minimally Invasive Cardiac Surgery and the Heart Valve Program at University of Louisville.

Dr. Grubb attended University of Southern California, Medical Degree from Keck School of Medicine and a Master of Health Administration. She completed general surgery residency at University of Illinois at Chicago (2010), fellowship in cardiothoracic surgery at University of Virginia (2012), and fellowship in interventional cardiology and transcatheter therapies at New York Presbyterian-Columbia University (2013).

Presentation(s):

• CARDIOTUBE INTERIVEW: Life time management what are the priorities

  Sunday, February 26, 2023
  4:30 PM – 4:40 PM ET

  Disclosure information not submitted.

• LATE-BREAKING TRIALS | SESSION TWO

  Sunday, February 26, 2023
  8:00 AM – 9:00 AM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• PERCUTANEOUS MITRAL VALVE REPLACEMENT: PRELIMINARY DATA REPORTS TECHNOLOGIES

  Sunday, February 26, 2023
  9:45 AM – 12:00 PM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• Panel Discussion: What Is the Best Management of MR-Percutaneous Valve Repair or Replacement?

  Sunday, February 26, 2023
  11:37 AM – 12:00 PM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• Optimize PRO Clinical Study Interim Analysis

  Sunday, February 26, 2023
  12:56 PM – 1:08 PM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• Panel Discussion and Closing Remarks

  Sunday, February 26, 2023
  1:20 PM – 1:30 PM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• CRT VALVE AORTIC: TAVR & PMVR: STATE OF THE FIELDS

  Monday, February 27, 2023
  8:00 AM – 11:30 AM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• Live Case from Piedmont Hospital | Atlanta, Georgia

  Monday, February 27, 2023
  8:00 AM – 8:55 AM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• Live Case from Medizinische Klinik, St. Johannes Hospital Dortmund | Dortmund, Germany

  Monday, February 27, 2023
  8:55 AM – 9:40 AM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• Power Break Symposium: Women in Cardiology - Live Case from Mount Sinai Hospital | New York, NY(Non-CME)

  Monday, February 27, 2023
  12:00 PM – 12:45 PM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• Valve Aortic (Non-CME)

  Monday, February 27, 2023
  1:30 PM – 5:45 PM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• LIFETIME MANAGEMENT POST TAVR AND VALVE IN VALVE

  Monday, February 27, 2023
  2:25 PM – 4:00 PM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• TAV-in-TAV Planning for the Second TAVR

  Monday, February 27, 2023
  2:41 PM – 2:49 PM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• Panel Discussion: Lifetime Management of Patients and Valve in with Severe AS

  Monday, February 27, 2023
  3:29 PM – 3:52 PM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

• AccuCinch Case-in-a-Box

  Tuesday, February 28, 2023
  7:45 AM – 8:00 AM ET

  Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)